Field assessment of BinaxNOW antigen tests as COVID-19 treatment entry point at a community testing site in San Francisco during evolving omicron surges

COVID-19 oral treatments require initiation within 5 days of symptom onset. Although antigen tests are less sensitive than RT-PCR, rapid results could facilitate entry to treatment. We collected anterior nasal swabs for BinaxNOW and RT-PCR testing and clinical data at a walk-up, community site in Sa...

Descripción completa

Detalles Bibliográficos
Autores principales: Schrom, John, Marquez, Carina, Wang, Chung-Yu, Saxena, Aditi, Mitchell, Anthea M., Ribeiro, Salu, Pilarowski, Genay, Nakamura, Robert, Rojas, Susana, Black, Douglas, Contreras Oseguera, Maria G., Diaz, Edgar Castellanos, Payan, Joselin, Rojas, Susy, Jones, Diane, Tulier-Laiwa, Valerie, Zavaleta, Aleks, Martinez, Jacqueline, Chamie, Gabriel, Glaser, Carol, Jacobson, Kathy, Petersen, Maya, DeRisi, Joseph, Havlir, Diane V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10038282/
https://www.ncbi.nlm.nih.gov/pubmed/36961855
http://dx.doi.org/10.1371/journal.pone.0283576

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10038282/
https://www.ncbi.nlm.nih.gov/pubmed/36961855
http://dx.doi.org/10.1371/journal.pone.0283576

Ejemplares similares